Dr. Ajay K. Nooka, MD

Dr. Nooka practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Nooka's NPI, 1801000260, was assigned on May 9, 2007. Dr. Nooka holds Georgia license 063380.

Dr. Nooka's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Nooka's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Nooka is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Nooka to 3 more hospitals, 2 group practices and clinics, 1 clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nooka practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Nooka's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Nooka is licensed in Georgia.

CMS data shows 662 Medicare services from Dr. Nooka across 7 procedure codes in 2024, for 232 Medicare patients. Medicare paid $36,504 for them.

CMS counts 232 Medicare patients who saw Dr. Nooka in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nooka's median patient age at 71, with 55% women.

In 2024, Dr. Nooka wrote 1,570 Medicare Part D claims for 237 patients. 57% of them were for generic drugs. CMS names the drug for 1,322 of them, across 22 drugs with 11 or more claims each, at $12,017,378 in total drug cost. In 2023, CMS named 1,353 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Nooka for performance year 2024, reported through an alternative payment model (APM). Dr. Nooka accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nooka as offering telehealth.

Dmand AI links 169 papers to Dr. Nooka, published from 2010 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Dexamethasone. Dr. Nooka has published most often in Cancer. Dr. Nooka's most frequent co-authors are Sagar Lonial, MD, Nisha Sara Joseph, MD and Craig C. Hofmeister, MD.

Dmand AI links Dr. Nooka to 10 clinical trials, 6 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders. GlaxoSmithKline sponsors the most, 4.

CMS Open Payments shows 230 general payments to Dr. Nooka from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Janssen Research & Development, LLC paid the most, $77,533. It also lists 41 research payments totaling $36,304 from 2017 to 2025.